Cargando…
Identification of Biomarkers for Preeclampsia Based on Metabolomics
BACKGROUND: Preeclampsia (PE) is a significant cause of maternal and neonatal morbidity and mortality worldwide. However, the pathogenesis of PE is unclear and reliable early diagnostic methods are still lacking. The purpose of this review is to summarize potential metabolic biomarkers and pathways...
Autores principales: | Yao, Mengxin, Xiao, Yue, Yang, Zhuoqiao, Ge, Wenxin, Liang, Fei, Teng, Haoyue, Gu, Yingjie, Yin, Jieyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943653/ https://www.ncbi.nlm.nih.gov/pubmed/35342309 http://dx.doi.org/10.2147/CLEP.S353019 |
Ejemplares similares
-
Application of metabolomics in intrahepatic cholestasis of pregnancy: a systematic review
por: Yang, Zhuoqiao, et al.
Publicado: (2022) -
The Exploration of Fetal Growth Restriction Based on Metabolomics: A Systematic Review
por: Yao, Mengxin, et al.
Publicado: (2022) -
Aspirin 75 mg to prevent preeclampsia in high-risk pregnancies: a retrospective real-world study in China
por: Xiao, Yue, et al.
Publicado: (2023) -
Impact of SARS-CoV-2 Infection During Pregnancy on Infant Neurobehavioral Development: A Case-Control Study
por: Cheng, Yao, et al.
Publicado: (2021) -
Corrigendum: Impact of SARS-CoV-2 Infection During Pregnancy on Infant Neurobehavioral Development: A Case-Control Study
por: Cheng, Yao, et al.
Publicado: (2022)